这是一篇来自已证抗体库的有关人类 NLRP3的综述,是根据121篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合NLRP3 抗体。
NLRP3 同义词: AGTAVPRL; AII; AVP; C1orf7; CIAS1; CLR1.1; DFNA34; FCAS; FCAS1; FCU; KEFH; MWS; NALP3; PYPAF1

艾博抗(上海)贸易有限公司
domestic rabbit 单克隆(EPR23094-1)
  • 免疫印迹; 大鼠; 1:1000; 图 4b
艾博抗(上海)贸易有限公司 NLRP3抗体(Abcam, ab263899)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 4b). Front Pharmacol (2021) ncbi
domestic rabbit 单克隆(EPR23094-1)
  • 免疫印迹; 小鼠; 1:1000; 图 4d
艾博抗(上海)贸易有限公司 NLRP3抗体(Abcam, 263899)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 4d). J Neuroinflammation (2021) ncbi
domestic rabbit 单克隆(EPR23094-1)
  • 免疫组化; 小鼠; 1:200; 图 5c
艾博抗(上海)贸易有限公司 NLRP3抗体(Abcam, Ab263899)被用于被用于免疫组化在小鼠样本上浓度为1:200 (图 5c). J Cell Mol Med (2021) ncbi
domestic goat 多克隆
  • 免疫组化; 小鼠; 1:200; 图 2c
艾博抗(上海)贸易有限公司 NLRP3抗体(Abcam, ab4207)被用于被用于免疫组化在小鼠样本上浓度为1:200 (图 2c). J Inflamm Res (2021) ncbi
domestic rabbit 多克隆
  • 免疫印迹基因敲除验证; 小鼠; 1:1000; 图 5d
艾博抗(上海)贸易有限公司 NLRP3抗体(Abcam, ab214185)被用于被用于免疫印迹基因敲除验证在小鼠样本上浓度为1:1000 (图 5d). Int J Mol Med (2021) ncbi
domestic rabbit 多克隆
  • 免疫组化; 小鼠; 1:200
艾博抗(上海)贸易有限公司 NLRP3抗体(Abcam, ab214185)被用于被用于免疫组化在小鼠样本上浓度为1:200. Aging Cell (2021) ncbi
domestic rabbit 单克隆(EPR23094-1)
  • 免疫细胞化学; 小鼠; 图 2c
  • 免疫组化; 小鼠; 图 6a
  • 免疫印迹; 小鼠; 图 2d
艾博抗(上海)贸易有限公司 NLRP3抗体(Abcam, ab263899)被用于被用于免疫细胞化学在小鼠样本上 (图 2c), 被用于免疫组化在小鼠样本上 (图 6a) 和 被用于免疫印迹在小鼠样本上 (图 2d). Front Cell Dev Biol (2021) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:500; 图 1a
艾博抗(上海)贸易有限公司 NLRP3抗体(Abcam, ab214185)被用于被用于免疫印迹在小鼠样本上浓度为1:500 (图 1a). Mol Med Rep (2021) ncbi
domestic goat 多克隆
  • 免疫细胞化学; 人类; 1:100; 图 1b
艾博抗(上海)贸易有限公司 NLRP3抗体(Abcam, ab4207)被用于被用于免疫细胞化学在人类样本上浓度为1:100 (图 1b). Science (2020) ncbi
domestic goat 多克隆
  • 免疫细胞化学; 大鼠; 1:200; 图 3i
艾博抗(上海)贸易有限公司 NLRP3抗体(Abcam, ab4207)被用于被用于免疫细胞化学在大鼠样本上浓度为1:200 (图 3i). Bone Res (2020) ncbi
domestic rabbit 多克隆
  • 免疫组化; 小鼠; 1:200; 图 8
  • 免疫印迹; 小鼠; 1:1000; 图 7a
艾博抗(上海)贸易有限公司 NLRP3抗体(Abcam, ab214185)被用于被用于免疫组化在小鼠样本上浓度为1:200 (图 8) 和 被用于免疫印迹在小鼠样本上浓度为1:1000 (图 7a). J Transl Med (2020) ncbi
domestic goat 多克隆
  • 免疫组化-冰冻切片; 大鼠; 1:200; 图 2d
艾博抗(上海)贸易有限公司 NLRP3抗体(Abcam, ab4207)被用于被用于免疫组化-冰冻切片在大鼠样本上浓度为1:200 (图 2d). Front Neurosci (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 大鼠; 1:500; 图 7a
艾博抗(上海)贸易有限公司 NLRP3抗体(Abcam, ab214185)被用于被用于免疫印迹在大鼠样本上浓度为1:500 (图 7a). Oxid Med Cell Longev (2020) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:500; 图 1c
艾博抗(上海)贸易有限公司 NLRP3抗体(abcam, ab214185)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 1c). BMC Cardiovasc Disord (2019) ncbi
domestic goat 多克隆
  • 免疫组化-石蜡切片; 小鼠; 图 3d
艾博抗(上海)贸易有限公司 NLRP3抗体(Abcam, ab4207)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 3d). Front Immunol (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 4h
艾博抗(上海)贸易有限公司 NLRP3抗体(Abcam, ab214185)被用于被用于免疫印迹在人类样本上 (图 4h). Aging (Albany NY) (2019) ncbi
domestic goat 多克隆
  • proximity ligation assay; 小鼠; 图 3b
艾博抗(上海)贸易有限公司 NLRP3抗体(Abcam, ab4207)被用于被用于proximity ligation assay在小鼠样本上 (图 3b). Cell Death Dis (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 11b
艾博抗(上海)贸易有限公司 NLRP3抗体(Abcam, ab214185)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 11b). Int J Mol Med (2018) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 大鼠; 1:500; 图 5c
艾博抗(上海)贸易有限公司 NLRP3抗体(Abcam, ab214185)被用于被用于免疫印迹在大鼠样本上浓度为1:500 (图 5c). Stroke (2018) ncbi
domestic goat 多克隆
  • 免疫印迹; 小鼠; 1:500; 图 4c
艾博抗(上海)贸易有限公司 NLRP3抗体(Abcam, ab4207)被用于被用于免疫印迹在小鼠样本上浓度为1:500 (图 4c). Clin Sci (Lond) (2017) ncbi
domestic goat 多克隆
  • 免疫印迹基因敲除验证; 小鼠; 1:1000; 图 4a
艾博抗(上海)贸易有限公司 NLRP3抗体(Abcam, ab4207)被用于被用于免疫印迹基因敲除验证在小鼠样本上浓度为1:1000 (图 4a). Behav Brain Res (2017) ncbi
domestic goat 多克隆
  • 免疫细胞化学; 人类; 1:100; 图 5a
  • 免疫印迹; 人类; 图 1a
艾博抗(上海)贸易有限公司 NLRP3抗体(Abcam, ab4207)被用于被用于免疫细胞化学在人类样本上浓度为1:100 (图 5a) 和 被用于免疫印迹在人类样本上 (图 1a). Pharmacol Res (2017) ncbi
domestic goat 多克隆
  • 免疫印迹; 小鼠; 图 8
艾博抗(上海)贸易有限公司 NLRP3抗体(Abcam, ab4207)被用于被用于免疫印迹在小鼠样本上 (图 8). Cell Death Dis (2016) ncbi
domestic goat 多克隆
  • 免疫印迹; 小鼠; 图 4C
艾博抗(上海)贸易有限公司 NLRP3抗体(Abcam, ab4207)被用于被用于免疫印迹在小鼠样本上 (图 4C). PLoS ONE (2016) ncbi
domestic goat 多克隆
  • 免疫印迹; 小鼠; 图 6a
艾博抗(上海)贸易有限公司 NLRP3抗体(Abcam, ab4207)被用于被用于免疫印迹在小鼠样本上 (图 6a). Science (2016) ncbi
Enzo Life Sciences
单克隆
  • 免疫印迹; 人类; 图 2e
Enzo Life Sciences NLRP3抗体(Enzo Life Sciences, ALX-804-881)被用于被用于免疫印迹在人类样本上 (图 2e). J Clin Invest (2018) ncbi
小鼠 单克隆(Nalpy3-b)
  • 免疫印迹; 人类; 图 5a
Enzo Life Sciences NLRP3抗体(Enzo Life Sciences, ALX-804-819-C100)被用于被用于免疫印迹在人类样本上 (图 5a). Nat Genet (2016) ncbi
小鼠 单克隆(Nalpy3-b)
  • 免疫印迹; 人类; 图 1
Enzo Life Sciences NLRP3抗体(Alexis Biocehmicals Enzo Life Sciences,, ALX-804-819)被用于被用于免疫印迹在人类样本上 (图 1). Arthritis Res Ther (2015) ncbi
单克隆
  • 免疫印迹; 人类; 1:500; 图 5d
Enzo Life Sciences NLRP3抗体(Enzo Life Sciences, ALX-804-881-C100)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 5d). Endocrinology (2015) ncbi
单克隆
  • 免疫印迹; 人类
  • 免疫印迹; 小鼠
Enzo Life Sciences NLRP3抗体(Enzo Life Sciences, ALX-804-881)被用于被用于免疫印迹在人类样本上 和 被用于免疫印迹在小鼠样本上. Microbes Infect (2014) ncbi
小鼠 单克隆(Nalpy3-b)
  • 免疫组化-石蜡切片; 人类; 1:100
  • 免疫细胞化学; 人类; 1:100
  • 免疫印迹; 人类; 1:1000
Enzo Life Sciences NLRP3抗体(Enzo Life Sciences, Nalpy3-b)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100, 被用于免疫细胞化学在人类样本上浓度为1:100 和 被用于免疫印迹在人类样本上浓度为1:1000. Invest Ophthalmol Vis Sci (2013) ncbi
小鼠 单克隆(Nalpy3-b)
  • 免疫组化-石蜡切片; 人类; 1:50
Enzo Life Sciences NLRP3抗体(Alexis, ALX-804-819-C100)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:50. J Invest Dermatol (2010) ncbi
小鼠 单克隆(Nalpy3-b)
  • 免疫印迹; 人类
Enzo Life Sciences NLRP3抗体(Alexis, ALX-804-819-C100)被用于被用于免疫印迹在人类样本上. Nat Immunol (2007) ncbi
Novus Biologicals
小鼠 单克隆(Nalpy3-b)
  • 免疫印迹; 小鼠; 图 5h
Novus Biologicals NLRP3抗体(Novus Biologicals, NBP1-97601)被用于被用于免疫印迹在小鼠样本上 (图 5h). Aging Dis (2021) ncbi
domestic rabbit 多克隆(14C8)
Novus Biologicals NLRP3抗体(Novus, NBP1-77080)被用于. J Neuroinflammation (2015) ncbi
圣克鲁斯生物技术
小鼠 单克隆(6F12)
  • 免疫印迹; 人类; 1:1000; 图 1
圣克鲁斯生物技术 NLRP3抗体(Santa Cruz, sc-134306)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 1). Biomed Res Int (2015) ncbi
小鼠 单克隆(6F12)
  • 免疫组化-冰冻切片; 人类
圣克鲁斯生物技术 NLRP3抗体(Santa, 6F12)被用于被用于免疫组化-冰冻切片在人类样本上. Hum Mol Genet (2011) ncbi
赛默飞世尔
domestic rabbit 多克隆
  • 免疫组化; 小鼠; 图 6a
赛默飞世尔 NLRP3抗体(Invitrogen, PA5-20,838))被用于被用于免疫组化在小鼠样本上 (图 6a). Sci Rep (2021) ncbi
Adipogen
小鼠 单克隆(Cryo-2)
  • 免疫印迹; 人类; 图 2e
  • 免疫印迹; 小鼠; 图 1k
Adipogen NLRP3抗体(AdipoGen Life Sciences, AG-20B-0014-C100)被用于被用于免疫印迹在人类样本上 (图 2e) 和 被用于免疫印迹在小鼠样本上 (图 1k). Cell Death Dis (2021) ncbi
单克隆
  • 免疫印迹; 小鼠; 图 6g
Adipogen NLRP3抗体(Adipogen, AG-20B-0014)被用于被用于免疫印迹在小鼠样本上 (图 6g). Sci Adv (2021) ncbi
单克隆
  • 免疫印迹; 小鼠; 图 1f
Adipogen NLRP3抗体(Adipogen, AG-20B-0014)被用于被用于免疫印迹在小鼠样本上 (图 1f). Front Immunol (2021) ncbi
单克隆
  • 免疫印迹; 小鼠; 图 3c
Adipogen NLRP3抗体(AdipoGen, AG-20B-0014)被用于被用于免疫印迹在小鼠样本上 (图 3c). J Neuroinflammation (2021) ncbi
单克隆
  • 免疫印迹; 小鼠; 1:1000; 图 2d
Adipogen NLRP3抗体(Adipogen, AG-20B-0014)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 2d). Antioxidants (Basel) (2021) ncbi
小鼠 单克隆(Cryo-2)
  • 免疫组化-冰冻切片; 小鼠; 1:500; 图 s1a
Adipogen NLRP3抗体(AdipoGen, AG-20B-0014-C100)被用于被用于免疫组化-冰冻切片在小鼠样本上浓度为1:500 (图 s1a). Sci Adv (2020) ncbi
小鼠 单克隆(Cryo-2)
  • 免疫印迹; 小鼠; 图 3e
Adipogen NLRP3抗体(AdipoGen, Cryo-2)被用于被用于免疫印迹在小鼠样本上 (图 3e). Sci Rep (2020) ncbi
单克隆
  • 免疫组化-石蜡切片; 人类; 1:200; 图 2c
  • 免疫组化-石蜡切片; 大鼠; 1:200; 图 2e
  • 免疫印迹; 大鼠; 1:1000; 图 3c
Adipogen NLRP3抗体(AdipoGen, AG-20B-0014)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200 (图 2c), 被用于免疫组化-石蜡切片在大鼠样本上浓度为1:200 (图 2e) 和 被用于免疫印迹在大鼠样本上浓度为1:1000 (图 3c). Bone Res (2020) ncbi
小鼠 单克隆(Cryo-2)
  • 免疫印迹; 小鼠; 1:1000; 图 2f
Adipogen NLRP3抗体(AdipoGen Life Sciences, AG-20B-0014-C100)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 2f). Sci Rep (2020) ncbi
小鼠 单克隆(Cryo-2)
  • 免疫印迹; 小鼠; 1:1000; 图 st6
Adipogen NLRP3抗体(Adipogen, AG-20B-0014-C100)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 st6). Sci Rep (2020) ncbi
单克隆
  • 免疫印迹; 小鼠; 1:1000; 图 1a
Adipogen NLRP3抗体(Adipogen, AG-20B-0014)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 1a). Int J Mol Sci (2020) ncbi
小鼠 单克隆(Cryo-2)
  • 免疫印迹; 小鼠; 1:1000; 图 2c
  • 免疫印迹; 人类; 1:1000; 图 1b
Adipogen NLRP3抗体(AdipoGen, AG-20B-0014-C100)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 2c) 和 被用于免疫印迹在人类样本上浓度为1:1000 (图 1b). Cell Mol Gastroenterol Hepatol (2020) ncbi
小鼠 单克隆(Cryo-1)
  • 免疫印迹; 小鼠; 1:1000; 图 5c
Adipogen NLRP3抗体(AdipoGen, AG-20B-0006)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 5c). CNS Neurosci Ther (2020) ncbi
小鼠 单克隆(Cryo-2)
  • proximity ligation assay; 小鼠; 图 3b
  • 免疫印迹; 小鼠; 图 s3e
Adipogen NLRP3抗体(Adipogen, Cryo-2)被用于被用于proximity ligation assay在小鼠样本上 (图 3b) 和 被用于免疫印迹在小鼠样本上 (图 s3e). Cell Death Dis (2019) ncbi
小鼠 单克隆(Cryo-2)
  • 免疫印迹; 人类; 图 1d
Adipogen NLRP3抗体(Adipogen, AG-20B-0014-C100)被用于被用于免疫印迹在人类样本上 (图 1d). Nature (2019) ncbi
单克隆
  • 免疫印迹基因敲除验证; 人类; 图 1a
Adipogen NLRP3抗体(Adipogen, AG-20B-0014)被用于被用于免疫印迹基因敲除验证在人类样本上 (图 1a). Proc Natl Acad Sci U S A (2019) ncbi
小鼠 单克隆(Cryo-2)
  • 免疫印迹; 人类; 图 s3f
Adipogen NLRP3抗体(Adipogen, Cryo-2)被用于被用于免疫印迹在人类样本上 (图 s3f). Nat Immunol (2019) ncbi
小鼠 单克隆(Cryo-2)
  • 免疫印迹; 小鼠; 图 1b
Adipogen NLRP3抗体(Adipogen, AG-20B-0014-C100)被用于被用于免疫印迹在小鼠样本上 (图 1b). Sci Adv (2019) ncbi
小鼠 单克隆(Cryo-2)
  • 免疫印迹; 小鼠; 图 2k
Adipogen NLRP3抗体(AdipoGen, AG-20B-0014-C100)被用于被用于免疫印迹在小鼠样本上 (图 2k). Cell Mol Gastroenterol Hepatol (2019) ncbi
单克隆
  • 免疫印迹; 小鼠; 图 1e
Adipogen NLRP3抗体(Adipogen, AG-20B-0014)被用于被用于免疫印迹在小鼠样本上 (图 1e). J Clin Invest (2019) ncbi
小鼠 单克隆(Cryo-2)
  • 免疫组化; 小鼠; 1:1000; 图 7a
  • 免疫印迹; 小鼠; 1:2000; 图 1d
Adipogen NLRP3抗体(AdipoGen, AG-20B-0014-C100)被用于被用于免疫组化在小鼠样本上浓度为1:1000 (图 7a) 和 被用于免疫印迹在小鼠样本上浓度为1:2000 (图 1d). J Cell Biol (2018) ncbi
单克隆
  • 免疫印迹; 小鼠; 图 3b
Adipogen NLRP3抗体(Adipogen, AG-20B-0014)被用于被用于免疫印迹在小鼠样本上 (图 3b). Front Immunol (2018) ncbi
小鼠 单克隆(Cryo-2)
  • 免疫印迹; 人类; 图 s16b
Adipogen NLRP3抗体(Adipogen, CRYO-2)被用于被用于免疫印迹在人类样本上 (图 s16b). J Clin Invest (2018) ncbi
单克隆
  • 免疫印迹基因敲除验证; 小鼠; 图 1g
Adipogen NLRP3抗体(Adipogen, AG-20B-0014)被用于被用于免疫印迹基因敲除验证在小鼠样本上 (图 1g). EBioMedicine (2018) ncbi
单克隆
  • 免疫印迹; 小鼠; 图 7e
Adipogen NLRP3抗体(AdipoGen, AG-20B-0014)被用于被用于免疫印迹在小鼠样本上 (图 7e). Immunity (2018) ncbi
小鼠 单克隆(Cryo-2)
  • 免疫印迹; 人类; 1:500; 图 2b
Adipogen NLRP3抗体(Adipogen, Cryo-2)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 2b). Nat Commun (2018) ncbi
单克隆
  • 免疫印迹基因敲除验证; 小鼠; 1:1000; 图 5e
  • 免疫沉淀; 小鼠; 图 8b
  • 免疫印迹; 小鼠; 1:1000; 图 5e
Adipogen NLRP3抗体(Adipogen, AG-20B-0014)被用于被用于免疫印迹基因敲除验证在小鼠样本上浓度为1:1000 (图 5e), 被用于免疫沉淀在小鼠样本上 (图 8b) 和 被用于免疫印迹在小鼠样本上浓度为1:1000 (图 5e). Nat Commun (2017) ncbi
单克隆
  • 免疫印迹; 人类; 1:1000; 图 s1b
Adipogen NLRP3抗体(Adipogen, AG-20B-0014)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 s1b). Nat Commun (2017) ncbi
单克隆
  • 免疫印迹基因敲除验证; 人类; 图 s1b
Adipogen NLRP3抗体(Adipogen, AG-20B-0014)被用于被用于免疫印迹基因敲除验证在人类样本上 (图 s1b). J Immunol (2017) ncbi
单克隆
  • 免疫印迹; 小鼠; 图 3c
Adipogen NLRP3抗体(R&D, AG-20B-0014)被用于被用于免疫印迹在小鼠样本上 (图 3c). PLoS Pathog (2017) ncbi
小鼠 单克隆(Cryo-2)
  • 免疫印迹; 小鼠; 图 s17b
Adipogen NLRP3抗体(AdipoGen Life Sciences, Cryo-2)被用于被用于免疫印迹在小鼠样本上 (图 s17b). Science (2017) ncbi
小鼠 单克隆(Cryo-2)
  • 免疫组化-石蜡切片; 小鼠; 图 6c
  • 免疫沉淀; 小鼠; 图 3g
  • 免疫印迹; 小鼠; 图 5c
  • 免疫沉淀; 人类; 图 3c
Adipogen NLRP3抗体(Adipogen, (AG-20B-0014-C100)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 6c), 被用于免疫沉淀在小鼠样本上 (图 3g), 被用于免疫印迹在小鼠样本上 (图 5c) 和 被用于免疫沉淀在人类样本上 (图 3c). Cell Death Dis (2016) ncbi
小鼠 单克隆(Cryo-2)
  • 免疫细胞化学; 人类; 图 s5
Adipogen NLRP3抗体(Adipogen, Cryo-2)被用于被用于免疫细胞化学在人类样本上 (图 s5). Respir Res (2016) ncbi
单克隆
  • 免疫印迹基因敲除验证; 小鼠; 图 3b
Adipogen NLRP3抗体(Adipogen, AG-20B-0014)被用于被用于免疫印迹基因敲除验证在小鼠样本上 (图 3b). J Cell Mol Med (2017) ncbi
小鼠 单克隆(Cryo-2)
  • EMSA; 人类; 图 5g
  • 免疫沉淀; 人类; 图 s8c
  • 免疫细胞化学; 人类; 1:100; 图 5a
  • 免疫印迹; 人类; 1:1000; 图 5e
Adipogen NLRP3抗体(Adipogen, AG-20B-0014-C100)被用于被用于EMSA在人类样本上 (图 5g), 被用于免疫沉淀在人类样本上 (图 s8c), 被用于免疫细胞化学在人类样本上浓度为1:100 (图 5a) 和 被用于免疫印迹在人类样本上浓度为1:1000 (图 5e). PLoS Pathog (2016) ncbi
单克隆
  • 免疫沉淀; 小鼠; 图 4
Adipogen NLRP3抗体(Adipogen, AG-20B-0014-C100)被用于被用于免疫沉淀在小鼠样本上 (图 4). Redox Biol (2016) ncbi
小鼠 单克隆(Cryo-2)
  • 免疫印迹; 人类; 1:1000; 图 6i
  • 免疫印迹; 小鼠; 1:1000; 图 1d
Adipogen NLRP3抗体(Adipogen, Cryo-2)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 6i) 和 被用于免疫印迹在小鼠样本上浓度为1:1000 (图 1d). Nat Immunol (2016) ncbi
单克隆
  • 免疫沉淀; 人类; 1:50; 图 6i
Adipogen NLRP3抗体(Adipogen, AG-20B-0014)被用于被用于免疫沉淀在人类样本上浓度为1:50 (图 6i). Nat Immunol (2016) ncbi
小鼠 单克隆(Cryo-2)
  • 流式细胞仪; 人类; 图 2d
  • 免疫细胞化学; 人类; 图 1e
Adipogen NLRP3抗体(Adipogen, AG-20B-0014-C100)被用于被用于流式细胞仪在人类样本上 (图 2d) 和 被用于免疫细胞化学在人类样本上 (图 1e). Science (2016) ncbi
单克隆
  • 免疫细胞化学; 人类; 1:200; 图 1
  • 免疫印迹; 人类; 1:200; 图 1
Adipogen NLRP3抗体(AdipoGen, AG-20B-0014-C100)被用于被用于免疫细胞化学在人类样本上浓度为1:200 (图 1) 和 被用于免疫印迹在人类样本上浓度为1:200 (图 1). Mol Brain (2016) ncbi
单克隆
  • 免疫印迹; 人类; 图 1
Adipogen NLRP3抗体(Adipogen, AG-20B-0014-C100)被用于被用于免疫印迹在人类样本上 (图 1). Toxins (Basel) (2016) ncbi
单克隆
  • 免疫印迹基因敲除验证; 小鼠; 图 s7
Adipogen NLRP3抗体(Adipogen, AG-20B-0014)被用于被用于免疫印迹基因敲除验证在小鼠样本上 (图 s7). Sci Rep (2016) ncbi
单克隆
  • 免疫印迹; 小鼠; 1:100; 图 5e
Adipogen NLRP3抗体(AdipoGen, AG-20B-0014)被用于被用于免疫印迹在小鼠样本上浓度为1:100 (图 5e). Cell Death Differ (2016) ncbi
小鼠 单克隆(Cryo-2)
  • 免疫沉淀; 人类; 图 1
  • 免疫印迹; 人类; 图 1
Adipogen NLRP3抗体(AdipoGen2, Cryo-2)被用于被用于免疫沉淀在人类样本上 (图 1) 和 被用于免疫印迹在人类样本上 (图 1). Nature (2016) ncbi
单克隆
  • 免疫印迹; 人类; 图 5c
  • 免疫印迹; 小鼠; 图 3a
Adipogen NLRP3抗体(Adipogen, AG-20B-0014)被用于被用于免疫印迹在人类样本上 (图 5c) 和 被用于免疫印迹在小鼠样本上 (图 3a). Am J Pathol (2016) ncbi
小鼠 单克隆(Cryo-2)
  • 免疫印迹基因敲除验证; 小鼠; 图 4
Adipogen NLRP3抗体(AdipoGen, cryo-2)被用于被用于免疫印迹基因敲除验证在小鼠样本上 (图 4). Nat Immunol (2016) ncbi
单克隆
  • 免疫印迹; 人类; 图 1c
Adipogen NLRP3抗体(Adipogen, AG-20B-0014-C100)被用于被用于免疫印迹在人类样本上 (图 1c). Nat Commun (2015) ncbi
单克隆
  • 免疫印迹; 大鼠; 1:1000; 图 5a
Adipogen NLRP3抗体(Adipogen, AG-20B-0014-C100)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 5a). PLoS ONE (2015) ncbi
小鼠 单克隆(Cryo-2)
  • 免疫印迹; 小鼠; 图 s6a
Adipogen NLRP3抗体(AdipoGen, Cryo-2)被用于被用于免疫印迹在小鼠样本上 (图 s6a). Nature (2015) ncbi
单克隆
  • 免疫细胞化学; 小鼠; 1:100
Adipogen NLRP3抗体(Adipogen, AG-20B-0014)被用于被用于免疫细胞化学在小鼠样本上浓度为1:100. Nat Immunol (2015) ncbi
单克隆
  • 免疫组化-石蜡切片; 大鼠; 1:200
Adipogen NLRP3抗体(Adipogen, AG-20B-0014)被用于被用于免疫组化-石蜡切片在大鼠样本上浓度为1:200. J Stroke Cerebrovasc Dis (2015) ncbi
单克隆
  • 免疫印迹; 大鼠; 1:500
Adipogen NLRP3抗体(AdipoGen, AG-20B-0014)被用于被用于免疫印迹在大鼠样本上浓度为1:500. J Pineal Res (2015) ncbi
小鼠 单克隆(Cryo-2)
  • 免疫沉淀; 人类; 图 1e
  • 免疫印迹; 人类; 图 1e
Adipogen NLRP3抗体(Adipogen, cryo-2)被用于被用于免疫沉淀在人类样本上 (图 1e) 和 被用于免疫印迹在人类样本上 (图 1e). J Biol Chem (2014) ncbi
单克隆
  • 免疫印迹; 人类
Adipogen NLRP3抗体(Adipogen, AG-20B-0014)被用于被用于免疫印迹在人类样本上. Cell Death Differ (2014) ncbi
小鼠 单克隆(Cryo-2)
  • 免疫印迹; 人类; 图 3a
Adipogen NLRP3抗体(AdipoGen, Cryo-2)被用于被用于免疫印迹在人类样本上 (图 3a). Innate Immun (2015) ncbi
赛信通(上海)生物试剂有限公司
domestic rabbit 单克隆(D2P5E)
  • 免疫印迹; 小鼠; 1:2000; 图 2g
赛信通(上海)生物试剂有限公司 NLRP3抗体(Cell signaling technology, 13158S)被用于被用于免疫印迹在小鼠样本上浓度为1:2000 (图 2g). Redox Biol (2021) ncbi
domestic rabbit 单克隆(D4D8T)
  • 免疫印迹; 小鼠; 图 1b
赛信通(上海)生物试剂有限公司 NLRP3抗体(Cell signaling, 15101)被用于被用于免疫印迹在小鼠样本上 (图 1b). Front Cell Dev Biol (2021) ncbi
domestic rabbit 单克隆(D4D8T)
  • 免疫印迹; 小鼠; 图 2f, 5d
赛信通(上海)生物试剂有限公司 NLRP3抗体(CST, 15101S)被用于被用于免疫印迹在小鼠样本上 (图 2f, 5d). Mediators Inflamm (2021) ncbi
domestic rabbit 单克隆(D4D8T)
  • 免疫印迹; 人类; 图 6b
赛信通(上海)生物试剂有限公司 NLRP3抗体(Cell Signaling, 15101)被用于被用于免疫印迹在人类样本上 (图 6b). Antioxidants (Basel) (2021) ncbi
domestic rabbit 单克隆(D4D8T)
  • 免疫印迹; 小鼠; 1:750; 图 7b
赛信通(上海)生物试剂有限公司 NLRP3抗体(CST, 15101)被用于被用于免疫印迹在小鼠样本上浓度为1:750 (图 7b). Basic Res Cardiol (2021) ncbi
domestic rabbit 单克隆(D2P5E)
  • 免疫印迹; 人类; 图 2c
赛信通(上海)生物试剂有限公司 NLRP3抗体(Cell signaling technology, 13158)被用于被用于免疫印迹在人类样本上 (图 2c). Front Cell Dev Biol (2021) ncbi
domestic rabbit 单克隆(D2P5E)
  • 免疫印迹基因敲除验证; 人类; 图 4c
赛信通(上海)生物试剂有限公司 NLRP3抗体(CST, 13158)被用于被用于免疫印迹基因敲除验证在人类样本上 (图 4c). Science (2021) ncbi
domestic rabbit 单克隆(D4D8T)
  • 免疫印迹; 小鼠; 1:1000; 图 4g
赛信通(上海)生物试剂有限公司 NLRP3抗体(Cell Signaling, 15101)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 4g). Front Immunol (2020) ncbi
domestic rabbit 单克隆(D4D8T)
  • 免疫沉淀; 小鼠; 图 5b
  • 免疫印迹; 小鼠; 1:2000; 图 5b
赛信通(上海)生物试剂有限公司 NLRP3抗体(CST, 15101)被用于被用于免疫沉淀在小鼠样本上 (图 5b) 和 被用于免疫印迹在小鼠样本上浓度为1:2000 (图 5b). FEBS Lett (2021) ncbi
domestic rabbit 单克隆(D4D8T)
  • 免疫印迹; 人类; 图 4b
赛信通(上海)生物试剂有限公司 NLRP3抗体(Cell Signaling Technology, 15101)被用于被用于免疫印迹在人类样本上 (图 4b). Front Oncol (2020) ncbi
domestic rabbit 单克隆(D2P5E)
  • 免疫印迹; 小鼠; 图 6
赛信通(上海)生物试剂有限公司 NLRP3抗体(Cell signaling, 13158)被用于被用于免疫印迹在小鼠样本上 (图 6). Int J Mol Sci (2020) ncbi
domestic rabbit 单克隆(D4D8T)
  • 免疫印迹; 小鼠; 1:1000; 图 7a, 7b
赛信通(上海)生物试剂有限公司 NLRP3抗体(CST, 15101)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 7a, 7b). Theranostics (2020) ncbi
domestic rabbit 单克隆(D2P5E)
  • 免疫沉淀; 小鼠; 图 1a, 1e, 6f, 6g
  • 免疫印迹; 小鼠; 图 6g, 6h, 6i
赛信通(上海)生物试剂有限公司 NLRP3抗体(Cell Signaling Technology, D2P5E)被用于被用于免疫沉淀在小鼠样本上 (图 1a, 1e, 6f, 6g) 和 被用于免疫印迹在小鼠样本上 (图 6g, 6h, 6i). PLoS Pathog (2020) ncbi
domestic rabbit 单克隆(D4D8T)
  • 免疫印迹; 小鼠; 图 s7a
赛信通(上海)生物试剂有限公司 NLRP3抗体(CST, 15101S)被用于被用于免疫印迹在小鼠样本上 (图 s7a). J Clin Invest (2020) ncbi
domestic rabbit 单克隆(D4D8T)
  • 免疫组化-石蜡切片; 人类; 图 1c
  • 免疫印迹; 人类; 图 1b
赛信通(上海)生物试剂有限公司 NLRP3抗体(Cell Signaling, 15101)被用于被用于免疫组化-石蜡切片在人类样本上 (图 1c) 和 被用于免疫印迹在人类样本上 (图 1b). Cancers (Basel) (2020) ncbi
domestic rabbit 单克隆(D4D8T)
  • 免疫印迹; 小鼠; 1:1000; 图 3b, 4f, s7b
赛信通(上海)生物试剂有限公司 NLRP3抗体(CST, 15101S)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 3b, 4f, s7b). Nat Commun (2019) ncbi
domestic rabbit 单克隆(D2P5E)
  • 免疫印迹; 人类; 1:500; 图 4i
赛信通(上海)生物试剂有限公司 NLRP3抗体(Cell Signaling, D2P5E)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 4i). Nat Immunol (2020) ncbi
domestic rabbit 单克隆(D2P5E)
  • 免疫印迹; 人类; 图 2j
赛信通(上海)生物试剂有限公司 NLRP3抗体(Cell Signaling, 13158)被用于被用于免疫印迹在人类样本上 (图 2j). Nat Commun (2019) ncbi
domestic rabbit 单克隆(D4D8T)
  • 免疫印迹; 大鼠; 图 6b
赛信通(上海)生物试剂有限公司 NLRP3抗体(Cell Signaling Technology, 15101)被用于被用于免疫印迹在大鼠样本上 (图 6b). Biomed Pharmacother (2019) ncbi
domestic rabbit 单克隆(D4D8T)
  • 免疫印迹基因敲除验证; 小鼠; 图 2s1b
赛信通(上海)生物试剂有限公司 NLRP3抗体(Cell Signaling, 15101)被用于被用于免疫印迹基因敲除验证在小鼠样本上 (图 2s1b). elife (2019) ncbi
domestic rabbit 单克隆(D4D8T)
  • 免疫印迹基因敲除验证; 小鼠; 图 2b
赛信通(上海)生物试剂有限公司 NLRP3抗体(CST, 15101S)被用于被用于免疫印迹基因敲除验证在小鼠样本上 (图 2b). PLoS Pathog (2019) ncbi
domestic rabbit 单克隆(D2P5E)
  • 免疫印迹; 人类; 图 2c, 5a
赛信通(上海)生物试剂有限公司 NLRP3抗体(Cell Signaling, 13158S)被用于被用于免疫印迹在人类样本上 (图 2c, 5a). J Allergy Clin Immunol (2019) ncbi
domestic rabbit 单克隆(D2P5E)
  • 免疫印迹基因敲除验证; 人类; 图 2a
  • 免疫印迹; 人类; 图 2a
赛信通(上海)生物试剂有限公司 NLRP3抗体(Cell Signaling, 13158)被用于被用于免疫印迹基因敲除验证在人类样本上 (图 2a) 和 被用于免疫印迹在人类样本上 (图 2a). MBio (2019) ncbi
domestic rabbit 单克隆(D4D8T)
  • 免疫印迹; 小鼠; 图 4d, 4e
赛信通(上海)生物试剂有限公司 NLRP3抗体(Cell Signaling Technology, 15101)被用于被用于免疫印迹在小鼠样本上 (图 4d, 4e). JCI Insight (2019) ncbi
domestic rabbit 单克隆(D4D8T)
  • 免疫印迹基因敲除验证; 小鼠; 1:1000; 图 s7j
赛信通(上海)生物试剂有限公司 NLRP3抗体(Cell Signaling, 15101)被用于被用于免疫印迹基因敲除验证在小鼠样本上浓度为1:1000 (图 s7j). Nat Commun (2018) ncbi
domestic rabbit 单克隆(D4D8T)
  • 免疫印迹; 小鼠; 1:800; 图 2c
赛信通(上海)生物试剂有限公司 NLRP3抗体(Cell Signaling, 15101)被用于被用于免疫印迹在小鼠样本上浓度为1:800 (图 2c). Cell Death Dis (2018) ncbi
domestic rabbit 单克隆(D4D8T)
  • 免疫印迹; 人类; 图 5a
赛信通(上海)生物试剂有限公司 NLRP3抗体(Cell Signaling Technology, 15101)被用于被用于免疫印迹在人类样本上 (图 5a). Sci Rep (2018) ncbi
domestic rabbit 单克隆(D4D8T)
  • 免疫印迹; 小鼠; 1:1000; 图 6g
赛信通(上海)生物试剂有限公司 NLRP3抗体(Cell Signaling, 15101)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 6g). Front Pharmacol (2017) ncbi
domestic rabbit 单克隆(D4D8T)
  • 免疫印迹; 人类; 1:1000; 图 9c
赛信通(上海)生物试剂有限公司 NLRP3抗体(Cell Signaling, 15101)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 9c). Sci Rep (2017) ncbi
domestic rabbit 单克隆(D4D8T)
  • 免疫细胞化学; 人类; 1:50; 图 6
  • 免疫印迹; 人类; 1:1000; 图 s1
赛信通(上海)生物试剂有限公司 NLRP3抗体(Cell Signaling, 15101 S)被用于被用于免疫细胞化学在人类样本上浓度为1:50 (图 6) 和 被用于免疫印迹在人类样本上浓度为1:1000 (图 s1). Sci Rep (2016) ncbi
domestic rabbit 单克隆(D2P5E)
  • 免疫印迹; 人类; 图 4b
赛信通(上海)生物试剂有限公司 NLRP3抗体(Cell Signaling, 13158S)被用于被用于免疫印迹在人类样本上 (图 4b). Cell Death Dis (2016) ncbi
domestic rabbit 单克隆(D2P5E)
  • 免疫印迹; 大鼠; 图 7d
赛信通(上海)生物试剂有限公司 NLRP3抗体(Cell Signaling, 13158)被用于被用于免疫印迹在大鼠样本上 (图 7d). Sci Rep (2016) ncbi
文章列表
  1. Zhang C, Zhao M, Wang B, Su Z, Guo B, Qin L, et al. The Nrf2-NLRP3-caspase-1 axis mediates the neuroprotective effects of Celastrol in Parkinson's disease. Redox Biol. 2021;47:102134 pubmed 出版商
  2. Zheng J, Yao L, Zhou Y, Gu X, Wang C, Bao K, et al. A novel function of NLRP3 independent of inflammasome as a key transcription factor of IL-33 in epithelial cells of atopic dermatitis. Cell Death Dis. 2021;12:871 pubmed 出版商
  3. Kong L, Zhang H, Lu C, Shi K, Huang H, Zheng Y, et al. AICAR, an AMP-Activated Protein Kinase Activator, Ameliorates Acute Pancreatitis-Associated Liver Injury Partially Through Nrf2-Mediated Antioxidant Effects and Inhibition of NLRP3 Inflammasome Activation. Front Pharmacol. 2021;12:724514 pubmed 出版商
  4. Zeng H, Chen H, Li M, Zhuang J, Peng Y, Zhou H, et al. Autophagy protein NRBF2 attenuates endoplasmic reticulum stress-associated neuroinflammation and oxidative stress via promoting autophagosome maturation by interacting with Rab7 after SAH. J Neuroinflammation. 2021;18:210 pubmed 出版商
  5. Cheng C, Xue F, Sui W, Meng L, Xie L, Zhang C, et al. Deletion of natriuretic peptide receptor C alleviates adipose tissue inflammation in hypercholesterolemic Apolipoprotein E knockout mice. J Cell Mol Med. 2021;25:9837-9850 pubmed 出版商
  6. Cheng J, Dong Y, Ma J, Pan R, Liao Y, Kong X, et al. Microglial Calhm2 regulates neuroinflammation and contributes to Alzheimer's disease pathology. Sci Adv. 2021;7: pubmed 出版商
  7. Ma M, Li G, Qi M, Jiang W, Zhou R. Inhibition of the Inflammasome Activity of NLRP3 Attenuates HDM-Induced Allergic Asthma. Front Immunol. 2021;12:718779 pubmed 出版商
  8. Opoku E, TRAUGHBER C, Zhang D, Iacano A, Khan M, Han J, et al. Gasdermin D Mediates Inflammation-Induced Defects in Reverse Cholesterol Transport and Promotes Atherosclerosis. Front Cell Dev Biol. 2021;9:715211 pubmed 出版商
  9. Zou Y, Bhat O, Yuan X, Li G, Huang D, Guo Y, et al. Release and Actions of Inflammatory Exosomes in Pulmonary Emphysema: Potential Therapeutic Target of Acupuncture. J Inflamm Res. 2021;14:3501-3521 pubmed 出版商
  10. Zhao J, Chen J, Li Y, Xia L, Wu Y. Bruton's tyrosine kinase regulates macrophage‑induced inflammation in the diabetic kidney via NLRP3 inflammasome activation. Int J Mol Med. 2021;48: pubmed 出版商
  11. Poudel S, Dixit M, Yildirim G, Cordoba Chacon J, Gahete M, Yuji I, et al. Sexual dimorphic impact of adult-onset somatopause on life span and age-induced osteoarthritis. Aging Cell. 2021;20:e13427 pubmed 出版商
  12. Ning J, He K, Cheng F, Li W, Yu W, Li H, et al. Long Non-coding RNA MEG3 Promotes Pyroptosis in Testicular Ischemia-Reperfusion Injury by Targeting MiR-29a to Modulate PTEN Expression. Front Cell Dev Biol. 2021;9:671613 pubmed 出版商
  13. Kong W, Tsuyama N, Inoue H, Guo Y, Mokuda S, Nobukiyo A, et al. Long-chain saturated fatty acids in breast milk are associated with the pathogenesis of atopic dermatitis via induction of inflammatory ILC3s. Sci Rep. 2021;11:13109 pubmed 出版商
  14. Li D, Liu M, Li Z, Zheng G, Chen A, Zhao L, et al. Sterol-resistant SCAP Overexpression in Vascular Smooth Muscle Cells Accelerates Atherosclerosis by Increasing Local Vascular Inflammation through Activation of the NLRP3 Inflammasome in Mice. Aging Dis. 2021;12:747-763 pubmed 出版商
  15. Chen J, Yang F, Shi S, Liu X, Qin F, Wei X, et al. The Severity of CVB3-Induced Myocarditis Can Be Improved by Blocking the Orchestration of NLRP3 and Th17 in Balb/c Mice. Mediators Inflamm. 2021;2021:5551578 pubmed 出版商
  16. Zhang Z, Gu X, Zhao X, He X, Shi H, Zhang K, et al. NLRP3 ablation enhances tolerance in heat stroke pathology by inhibiting IL-1β-mediated neuroinflammation. J Neuroinflammation. 2021;18:128 pubmed 出版商
  17. Lee S, Kim J, Choi Y, Gong J, Park S, Douangdeuane B, et al. Therapeutic Effects of Dipterocarpus tuberculatus with High Antioxidative Activity Against UV-Induced Photoaging of NHDF Cells and Nude Mice. Antioxidants (Basel). 2021;10: pubmed 出版商
  18. Olcum M, Tufekci K, Durur D, Tastan B, Gokbayrak I, Genc K, et al. Ethyl Pyruvate Attenuates Microglial NLRP3 Inflammasome Activation via Inhibition of HMGB1/NF-κB/miR-223 Signaling. Antioxidants (Basel). 2021;10: pubmed 出版商
  19. Su Y, Wang Y, Liu M, Chen H. Hydrogen sulfide attenuates renal I/R‑induced activation of the inflammatory response and apoptosis via regulating Nrf2‑mediated NLRP3 signaling pathway inhibition. Mol Med Rep. 2021;24: pubmed 出版商
  20. Frenis K, Helmstädter J, Ruan Y, Schramm E, Kalinovic S, Kröller Schön S, et al. Ablation of lysozyme M-positive cells prevents aircraft noise-induced vascular damage without improving cerebral side effects. Basic Res Cardiol. 2021;116:31 pubmed 出版商
  21. Chen Q, Liu X, Wang D, Zheng J, Chen L, Xie Q, et al. Periodontal Inflammation-Triggered by Periodontal Ligament Stem Cell Pyroptosis Exacerbates Periodontitis. Front Cell Dev Biol. 2021;9:663037 pubmed 出版商
  22. Wang Q, Gao H, Clark K, Mugisha C, Davis K, Tang J, et al. CARD8 is an inflammasome sensor for HIV-1 protease activity. Science. 2021;371: pubmed 出版商
  23. Jin X, Morro B, Tørresen O, Moiche V, Solbakken M, Jakobsen K, et al. Innovation in Nucleotide-Binding Oligomerization-Like Receptor and Toll-Like Receptor Sensing Drives the Major Histocompatibility Complex-II Free Atlantic Cod Immune System. Front Immunol. 2020;11:609456 pubmed 出版商
  24. Zhang X, Wang R, Hu D, Sun X, Fujioka H, Lundberg K, et al. Oligodendroglial glycolytic stress triggers inflammasome activation and neuropathology in Alzheimer's disease. Sci Adv. 2020;6: pubmed 出版商
  25. Zhang W, Tao S, Wang T, Zhang J, Liu X, Li Y, et al. ABRO1 stabilizes the deubiquitinase BRCC3 through inhibiting its degradation mediated by the E3 ubiquitin ligase WWP2. FEBS Lett. 2021;595:169-182 pubmed 出版商
  26. Sünderhauf A, Raschdorf A, Hicken M, Schlichting H, Fetzer F, Brethack A, et al. GC1qR Cleavage by Caspase-1 Drives Aerobic Glycolysis in Tumor Cells. Front Oncol. 2020;10:575854 pubmed 出版商
  27. Kim Y, Oh S, Ahn J, Yook J, Kim C, Park S, et al. The Crucial Role of Xanthine Oxidase in CKD Progression Associated with Hypercholesterolemia. Int J Mol Sci. 2020;21: pubmed 出版商
  28. Magupalli V, Negro R, Tian Y, Hauenstein A, Di Caprio G, Skillern W, et al. HDAC6 mediates an aggresome-like mechanism for NLRP3 and pyrin inflammasome activation. Science. 2020;369: pubmed 出版商
  29. Hu J, Wang H, Li X, Liu Y, Mi Y, Kong H, et al. Fibrinogen-like protein 2 aggravates nonalcoholic steatohepatitis via interaction with TLR4, eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder. Theranostics. 2020;10:9702-9720 pubmed 出版商
  30. Wang W, Hu D, Wu C, Feng Y, Li A, Liu W, et al. STING promotes NLRP3 localization in ER and facilitates NLRP3 deubiquitination to activate the inflammasome upon HSV-1 infection. PLoS Pathog. 2020;16:e1008335 pubmed 出版商
  31. Kim Y, Kim J, Gu S, Jo S, Kim S, Young Kim S, et al. Identification of highly potent and selective inhibitor, TIPTP, of the p22phox-Rubicon axis as a therapeutic agent for rheumatoid arthritis. Sci Rep. 2020;10:4570 pubmed 出版商
  32. Chen F, Jiang G, Liu H, Li Z, Pei Y, Wang H, et al. Melatonin alleviates intervertebral disc degeneration by disrupting the IL-1β/NF-κB-NLRP3 inflammasome positive feedback loop. Bone Res. 2020;8:10 pubmed 出版商
  33. Gao Y, Dai X, Li Y, Li G, Lin X, Ai C, et al. Role of Parkin-mediated mitophagy in the protective effect of polydatin in sepsis-induced acute kidney injury. J Transl Med. 2020;18:114 pubmed 出版商
  34. Wooff Y, Fernando N, Wong J, Dietrich C, Aggio Bruce R, Chu Tan J, et al. Caspase-1-dependent inflammasomes mediate photoreceptor cell death in photo-oxidative damage-induced retinal degeneration. Sci Rep. 2020;10:2263 pubmed 出版商
  35. Zhuang K, Zuo Y, Sherchan P, Wang J, Yan X, Liu F. Hydrogen Inhalation Attenuates Oxidative Stress Related Endothelial Cells Injury After Subarachnoid Hemorrhage in Rats. Front Neurosci. 2019;13:1441 pubmed 出版商
  36. Theivanthiran B, Evans K, Devito N, Plebanek M, Sturdivant M, Wachsmuth L, et al. A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti-PD-1 immunotherapy. J Clin Invest. 2020;130:2570-2586 pubmed 出版商
  37. Yu J, Wang W, Matei N, Li X, Pang J, Mo J, et al. Ezetimibe Attenuates Oxidative Stress and Neuroinflammation via the AMPK/Nrf2/TXNIP Pathway after MCAO in Rats. Oxid Med Cell Longev. 2020;2020:4717258 pubmed 出版商
  38. Svensson M, Andersson E, Manouchehrian O, Yang Y, Deierborg T. Voluntary running does not reduce neuroinflammation or improve non-cognitive behavior in the 5xFAD mouse model of Alzheimer's disease. Sci Rep. 2020;10:1346 pubmed 出版商
  39. Teng J, Mei Q, Zhou X, Tang Y, Xiong R, Qiu W, et al. Polyphyllin VI Induces Caspase-1-Mediated Pyroptosis via the Induction of ROS/NF-κB/NLRP3/GSDMD Signal Axis in Non-Small Cell Lung Cancer. Cancers (Basel). 2020;12: pubmed 出版商
  40. Gao Y, Tu D, Yang R, Chu C, Hong J, Gao H. Through Reducing ROS Production, IL-10 Suppresses Caspase-1-Dependent IL-1β Maturation, thereby Preventing Chronic Neuroinflammation and Neurodegeneration. Int J Mol Sci. 2020;21: pubmed 出版商
  41. Cai S, Ge M, Mennone A, Hoque R, Ouyang X, Boyer J. Inflammasome Is Activated in the Liver of Cholestatic Patients and Aggravates Hepatic Injury in Bile Duct-Ligated Mouse. Cell Mol Gastroenterol Hepatol. 2020;9:679-688 pubmed 出版商
  42. Quach C, Song Y, Guo H, Li S, Maazi H, Fung M, et al. A truncating mutation in the autophagy gene UVRAG drives inflammation and tumorigenesis in mice. Nat Commun. 2019;10:5681 pubmed 出版商
  43. Zewinger S, Reiser J, Jankowski V, Alansary D, Hahm E, Triem S, et al. Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation. Nat Immunol. 2020;21:30-41 pubmed 出版商
  44. Liu Y, Tie L. Apolipoprotein M and sphingosine-1-phosphate complex alleviates TNF-α-induced endothelial cell injury and inflammation through PI3K/AKT signaling pathway. BMC Cardiovasc Disord. 2019;19:279 pubmed 出版商
  45. Borghi M, Pariano M, Solito V, Puccetti M, Bellet M, Stincardini C, et al. Targeting the Aryl Hydrocarbon Receptor With Indole-3-Aldehyde Protects From Vulvovaginal Candidiasis via the IL-22-IL-18 Cross-Talk. Front Immunol. 2019;10:2364 pubmed 出版商
  46. Liu J, Yao L, Zhang M, Jiang J, Yang M, Wang Y. Downregulation of LncRNA-XIST inhibited development of non-small cell lung cancer by activating miR-335/SOD2/ROS signal pathway mediated pyroptotic cell death. Aging (Albany NY). 2019;11:7830-7846 pubmed 出版商
  47. Managò A, Audrito V, Mazzola F, Sorci L, Gaudino F, Gizzi K, et al. Extracellular nicotinate phosphoribosyltransferase binds Toll like receptor 4 and mediates inflammation. Nat Commun. 2019;10:4116 pubmed 出版商
  48. Zhang R, Liu Y, Chen Y, Li Q, Marshall C, Wu T, et al. Aquaporin 4 deletion exacerbates brain impairments in a mouse model of chronic sleep disruption. CNS Neurosci Ther. 2020;26:228-239 pubmed 出版商
  49. Qin W, Wu X, Jia Y, Tong X, Guo C, Chen D, et al. Suhuang antitussive capsule inhibits NLRP3 inflammasome activation and ameliorates pulmonary dysfunction via suppression of endoplasmic reticulum stress in cough variant asthma. Biomed Pharmacother. 2019;118:109188 pubmed 出版商
  50. Lim J, Park H, Heisler J, Maculins T, Roose Girma M, Xu M, et al. Autophagy regulates inflammatory programmed cell death via turnover of RHIM-domain proteins. elife. 2019;8: pubmed 出版商
  51. Dumont A, de Rosny C, Kieu T, Perrey S, Berger H, Fluckiger A, et al. Docosahexaenoic acid inhibits both NLRP3 inflammasome assembly and JNK-mediated mature IL-1β secretion in 5-fluorouracil-treated MDSC: implication in cancer treatment. Cell Death Dis. 2019;10:485 pubmed 出版商
  52. Sharif H, Wang L, Wang W, Magupalli V, Andreeva L, Qiao Q, et al. Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome. Nature. 2019;: pubmed 出版商
  53. Lin L, Xu L, Lv W, Han L, Xiang Y, Fu L, et al. An NLRP3 inflammasome-triggered cytokine storm contributes to Streptococcal toxic shock-like syndrome (STSLS). PLoS Pathog. 2019;15:e1007795 pubmed 出版商
  54. Gordon E, Yao X, Xu H, Karkowsky W, Kaler M, Kalchiem Dekel O, et al. Apolipoprotein E is a concentration-dependent pulmonary danger signal that activates the NLRP3 inflammasome and IL-1β secretion by bronchoalveolar fluid macrophages from asthmatic subjects. J Allergy Clin Immunol. 2019;: pubmed 出版商
  55. Davis M, Fairgrieve M, den Hartigh A, Yakovenko O, Duvvuri B, Lood C, et al. Calpain drives pyroptotic vimentin cleavage, intermediate filament loss, and cell rupture that mediates immunostimulation. Proc Natl Acad Sci U S A. 2019;116:5061-5070 pubmed 出版商
  56. Botto S, Abraham J, Mizuno N, Pryke K, Gall B, Landais I, et al. Human Cytomegalovirus Immediate Early 86-kDa Protein Blocks Transcription and Induces Degradation of the Immature Interleukin-1β Protein during Virion-Mediated Activation of the AIM2 Inflammasome. MBio. 2019;10: pubmed 出版商
  57. Choi Y, Kim S, Choi Y, Nielsen T, Yan J, Lu A, et al. SERPINB1-mediated checkpoint of inflammatory caspase activation. Nat Immunol. 2019;20:276-287 pubmed 出版商
  58. Huang X, Feng Z, Jiang Y, Li J, Xiang Q, Guo S, et al. VSIG4 mediates transcriptional inhibition of Nlrp3 and Il-1β in macrophages. Sci Adv. 2019;5:eaau7426 pubmed 出版商
  59. Kurundkar D, Kurundkar A, Bone N, Becker E, Liu W, Chacko B, et al. SIRT3 diminishes inflammation and mitigates endotoxin-induced acute lung injury. JCI Insight. 2019;4: pubmed 出版商
  60. Benmerzoug S, Rose S, Bounab B, Gosset D, Duneau L, Chenuet P, et al. STING-dependent sensing of self-DNA drives silica-induced lung inflammation. Nat Commun. 2018;9:5226 pubmed 出版商
  61. Kiyohara H, Sujino T, Teratani T, Miyamoto K, Arai M, Nomura E, et al. Toll-Like Receptor 7 Agonist-Induced Dermatitis Causes Severe Dextran Sulfate Sodium Colitis by Altering the Gut Microbiome and Immune Cells. Cell Mol Gastroenterol Hepatol. 2019;7:135-156 pubmed 出版商
  62. Sharma D, Malik A, Guy C, Vogel P, Kanneganti T. TNF/TNFR axis promotes pyrin inflammasome activation and distinctly modulates pyrin inflammasomopathy. J Clin Invest. 2019;129:150-162 pubmed 出版商
  63. Qiu T, Pei P, Yao X, Jiang L, Wei S, Wang Z, et al. Taurine attenuates arsenic-induced pyroptosis and nonalcoholic steatohepatitis by inhibiting the autophagic-inflammasomal pathway. Cell Death Dis. 2018;9:946 pubmed 出版商
  64. de la Roche M, Hamilton C, Mortensen R, Jeyaprakash A, Ghosh S, Anand P. Trafficking of cholesterol to the ER is required for NLRP3 inflammasome activation. J Cell Biol. 2018;217:3560-3576 pubmed 出版商
  65. Qu W, Wang Y, Wu Y, Liu Y, Chen K, Liu X, et al. Triggering Receptors Expressed on Myeloid Cells 2 Promotes Corneal Resistance Against Pseudomonas aeruginosa by Inhibiting Caspase-1-Dependent Pyroptosis. Front Immunol. 2018;9:1121 pubmed 出版商
  66. Lau A, Chung H, Komada T, Platnich J, Sandall C, Choudhury S, et al. Renal immune surveillance and dipeptidase-1 contribute to contrast-induced acute kidney injury. J Clin Invest. 2018;128:2894-2913 pubmed 出版商
  67. Chen Y, Qin X, An Q, Yi J, Feng F, Yin D, et al. Mesenchymal Stromal Cells Directly Promote Inflammation by Canonical NLRP3 and Non-canonical Caspase-11 Inflammasomes. EBioMedicine. 2018;32:31-42 pubmed 出版商
  68. Song H, Li X, Liu Y, Lu W, Cui Z, Zhou L, et al. Carnosic acid protects mice from high-fat diet-induced NAFLD by regulating MARCKS. Int J Mol Med. 2018;42:193-207 pubmed 出版商
  69. Mao L, Kitani A, Similuk M, Oler A, Albenberg L, Kelsen J, et al. Loss-of-function CARD8 mutation causes NLRP3 inflammasome activation and Crohn's disease. J Clin Invest. 2018;128:1793-1806 pubmed 出版商
  70. Czimmerer Z, Dániel B, Horvath A, Rückerl D, Nagy G, Kiss M, et al. The Transcription Factor STAT6 Mediates Direct Repression of Inflammatory Enhancers and Limits Activation of Alternatively Polarized Macrophages. Immunity. 2018;48:75-90.e6 pubmed 出版商
  71. Lagrange B, Benaoudia S, Wallet P, Magnotti F, Provost A, Michal F, et al. Human caspase-4 detects tetra-acylated LPS and cytosolic Francisella and functions differently from murine caspase-11. Nat Commun. 2018;9:242 pubmed 出版商
  72. Kosmidou C, Efstathiou N, Hoang M, Notomi S, Konstantinou E, Hirano M, et al. Issues with the Specificity of Immunological Reagents for NLRP3: Implications for Age-related Macular Degeneration. Sci Rep. 2018;8:461 pubmed 出版商
  73. Zhou K, Enkhjargal B, Xie Z, Sun C, Wu L, Malaguit J, et al. Dihydrolipoic Acid Inhibits Lysosomal Rupture and NLRP3 Through Lysosome-Associated Membrane Protein-1/Calcium/Calmodulin-Dependent Protein Kinase II/TAK1 Pathways After Subarachnoid Hemorrhage in Rat. Stroke. 2018;49:175-183 pubmed 出版商
  74. Tang T, Lang X, Xu C, Wang X, Gong T, Yang Y, et al. CLICs-dependent chloride efflux is an essential and proximal upstream event for NLRP3 inflammasome activation. Nat Commun. 2017;8:202 pubmed 出版商
  75. Bednash J, Weathington N, Londino J, Rojas M, Gulick D, Fort R, et al. Targeting the deubiquitinase STAMBP inhibits NALP7 inflammasome activity. Nat Commun. 2017;8:15203 pubmed 出版商
  76. Xiao N, Yang L, Yang Y, Liu L, Li J, Liu B, et al. Ginsenoside Rg5 Inhibits Succinate-Associated Lipolysis in Adipose Tissue and Prevents Muscle Insulin Resistance. Front Pharmacol. 2017;8:43 pubmed 出版商
  77. Gutierrez K, Davis M, Daniels B, Olsen T, Ralli Jain P, Tait S, et al. MLKL Activation Triggers NLRP3-Mediated Processing and Release of IL-1β Independently of Gasdermin-D. J Immunol. 2017;198:2156-2164 pubmed 出版商
  78. Koh H, Kim Y, Kim J, Yun J, Jang K, Yang C. Toxoplasma gondii GRA7-Targeted ASC and PLD1 Promote Antibacterial Host Defense via PKCα. PLoS Pathog. 2017;13:e1006126 pubmed 出版商
  79. Fuster J, MacLauchlan S, Zuriaga M, Polackal M, Ostriker A, Chakraborty R, et al. Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice. Science. 2017;355:842-847 pubmed 出版商
  80. Irrera N, Vaccaro M, Bitto A, Pallio G, Pizzino G, Lentini M, et al. BAY 11-7082 inhibits the NF-?B and NLRP3 inflammasome pathways and protects against IMQ-induced psoriasis. Clin Sci (Lond). 2017;131:487-498 pubmed 出版商
  81. Su W, Zhang Y, Chen Y, Gong H, Lian Y, Peng W, et al. NLRP3 gene knockout blocks NF-?B and MAPK signaling pathway in CUMS-induced depression mouse model. Behav Brain Res. 2017;322:1-8 pubmed 出版商
  82. Luan L, Patil N, Guo Y, Hernandez A, Bohannon J, Fensterheim B, et al. Comparative Transcriptome Profiles of Human Blood in Response to the Toll-like Receptor 4 Ligands Lipopolysaccharide and Monophosphoryl Lipid A. Sci Rep. 2017;7:40050 pubmed 出版商
  83. Jiang S, Zhang Y, Zheng J, Li X, Yao Y, Wu Y, et al. Potentiation of hepatic stellate cell activation by extracellular ATP is dependent on P2X7R-mediated NLRP3 inflammasome activation. Pharmacol Res. 2017;117:82-93 pubmed 出版商
  84. Wei C, Wang Y, Du Z, Guan K, Cao Y, Yang H, et al. The Yersinia Type III secretion effector YopM Is an E3 ubiquitin ligase that induced necrotic cell death by targeting NLRP3. Cell Death Dis. 2016;7:e2519 pubmed 出版商
  85. Burgy O, Bellaye P, Causse S, Beltramo G, Wettstein G, Boutanquoi P, et al. Pleural inhibition of the caspase-1/IL-1? pathway diminishes profibrotic lung toxicity of bleomycin. Respir Res. 2016;17:162 pubmed
  86. Hu Z, Zhang Y, Wang J, Mao P, Lv X, Yuan S, et al. Knockout of Ccr2 alleviates photoreceptor cell death in rodent retina exposed to chronic blue light. Cell Death Dis. 2016;7:e2468 pubmed 出版商
  87. Wang Y, Yan X, Mi S, Li Z, Wang Y, Zhu H, et al. Naoxintong attenuates Ischaemia/reperfusion Injury through inhibiting NLRP3 inflammasome activation. J Cell Mol Med. 2017;21:4-12 pubmed 出版商
  88. Alves da Costa T, Di Gangi R, Thomé R, Barreto Felisbino M, Pires Bonfanti A, Lumi Watanabe Ishikawa L, et al. Severe Changes in Thymic Microenvironment in a Chronic Experimental Model of Paracoccidioidomycosis. PLoS ONE. 2016;11:e0164745 pubmed 出版商
  89. Ambite I, Puthia M, Nagy K, Cafaro C, Nadeem A, Butler D, et al. Molecular Basis of Acute Cystitis Reveals Susceptibility Genes and Immunotherapeutic Targets. PLoS Pathog. 2016;12:e1005848 pubmed 出版商
  90. Tseng H, Vong C, Kwan Y, Lee S, Hoi M. TRPM2 regulates TXNIP-mediated NLRP3 inflammasome activation via interaction with p47 phox under high glucose in human monocytic cells. Sci Rep. 2016;6:35016 pubmed 出版商
  91. Du R, Wu F, Lu M, Shu X, Ding J, Wu G, et al. Uncoupling protein 2 modulation of the NLRP3 inflammasome in astrocytes and its implications in depression. Redox Biol. 2016;9:178-187 pubmed 出版商
  92. Mortimer L, Moreau F, MacDonald J, Chadee K. NLRP3 inflammasome inhibition is disrupted in a group of auto-inflammatory disease CAPS mutations. Nat Immunol. 2016;17:1176-86 pubmed 出版商
  93. Xing Y, Cao R, Hu H. TLR and NLRP3 inflammasome-dependent innate immune responses to tumor-derived autophagosomes (DRibbles). Cell Death Dis. 2016;7:e2322 pubmed 出版商
  94. Arbore G, West E, Spolski R, Robertson A, Klos A, Rheinheimer C, et al. T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4⁺ T cells. Science. 2016;352:aad1210 pubmed 出版商
  95. Kang L, Zhang D, Ma C, Zhang J, Jia K, Liu J, et al. Cinnamaldehyde and allopurinol reduce fructose-induced cardiac inflammation and fibrosis by attenuating CD36-mediated TLR4/6-IRAK4/1 signaling to suppress NLRP3 inflammasome activation. Sci Rep. 2016;6:27460 pubmed 出版商
  96. De Filippis L, Halikere A, McGowan H, Moore J, Tischfield J, Hart R, et al. Ethanol-mediated activation of the NLRP3 inflammasome in iPS cells and iPS cells-derived neural progenitor cells. Mol Brain. 2016;9:51 pubmed 出版商
  97. Ezekwe E, Weng C, Duncan J. ADAM10 Cell Surface Expression but Not Activity Is Critical for Staphylococcus aureus ?-Hemolysin-Mediated Activation of the NLRP3 Inflammasome in Human Monocytes. Toxins (Basel). 2016;8:95 pubmed 出版商
  98. de Torre Minguela C, Barberà Cremades M, Gómez A, Martín Sánchez F, Pelegrín P. Macrophage activation and polarization modify P2X7 receptor secretome influencing the inflammatory process. Sci Rep. 2016;6:22586 pubmed 出版商
  99. Martín Sánchez F, Diamond C, Zeitler M, Gómez A, Baroja Mazo A, Bagnall J, et al. Inflammasome-dependent IL-1β release depends upon membrane permeabilisation. Cell Death Differ. 2016;23:1219-31 pubmed 出版商
  100. He Y, Zeng M, Yang D, Motro B, Núñez G. NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux. Nature. 2016;530:354-7 pubmed 出版商
  101. Haque S, Lan X, Wen H, Lederman R, Chawla A, Attia M, et al. HIV Promotes NLRP3 Inflammasome Complex Activation in Murine HIV-Associated Nephropathy. Am J Pathol. 2016;186:347-58 pubmed 出版商
  102. Shi H, Wang Y, Li X, Zhan X, Tang M, Fina M, et al. NLRP3 activation and mitosis are mutually exclusive events coordinated by NEK7, a new inflammasome component. Nat Immunol. 2016;17:250-8 pubmed 出版商
  103. Zhou Q, Wang H, Schwartz D, Stoffels M, Park Y, Zhang Y, et al. Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease. Nat Genet. 2016;48:67-73 pubmed 出版商
  104. Viganò E, Diamond C, Spreafico R, Balachander A, Sobota R, Mortellaro A. Human caspase-4 and caspase-5 regulate the one-step non-canonical inflammasome activation in monocytes. Nat Commun. 2015;6:8761 pubmed 出版商
  105. Mocanu A, Mulya A, Huang H, Dan O, Shimizu H, Batayyah E, et al. Effect of Roux-en-Y Gastric Bypass on the NLRP3 Inflammasome in Adipose Tissue from Obese Rats. PLoS ONE. 2015;10:e0139764 pubmed 出版商
  106. Choulaki C, Papadaki G, Repa A, Kampouraki E, Kambas K, Ritis K, et al. Enhanced activity of NLRP3 inflammasome in peripheral blood cells of patients with active rheumatoid arthritis. Arthritis Res Ther. 2015;17:257 pubmed 出版商
  107. Kayagaki N, Stowe I, Lee B, O Rourke K, Anderson K, Warming S, et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature. 2015;526:666-71 pubmed 出版商
  108. Shirasuna K, Karasawa T, Usui F, Kobayashi M, Komada T, Kimura H, et al. NLRP3 Deficiency Improves Angiotensin II-Induced Hypertension But Not Fetal Growth Restriction During Pregnancy. Endocrinology. 2015;156:4281-92 pubmed 出版商
  109. Woolery K, Mohamed M, Linger R, Dobrinski K, Roman J, Kruk P. BRCA1 185delAG Mutation Enhances Interleukin-1β Expression in Ovarian Surface Epithelial Cells. Biomed Res Int. 2015;2015:652017 pubmed 出版商
  110. Chi W, Chen H, Li F, Zhu Y, Yin W, Zhuo Y. HMGB1 promotes the activation of NLRP3 and caspase-8 inflammasomes via NF-κB pathway in acute glaucoma. J Neuroinflammation. 2015;12:137 pubmed 出版商
  111. Bruchard M, Rebé C, Derangère V, Togbé D, Ryffel B, Boidot R, et al. The receptor NLRP3 is a transcriptional regulator of TH2 differentiation. Nat Immunol. 2015;16:859-70 pubmed 出版商
  112. Kono S, Kurata T, Sato K, Omote Y, Hishikawa N, Yamashita T, et al. Neurovascular protection by telmisartan via reducing neuroinflammation in stroke-resistant spontaneously hypertensive rat brain after ischemic stroke. J Stroke Cerebrovasc Dis. 2015;24:537-47 pubmed 出版商
  113. Ortiz F, Acuña Castroviejo D, Doerrier C, Dayoub J, López L, Venegas C, et al. Melatonin blunts the mitochondrial/NLRP3 connection and protects against radiation-induced oral mucositis. J Pineal Res. 2015;58:34-49 pubmed 出版商
  114. Giguère P, Gall B, Ezekwe E, Laroche G, Buckley B, Kebaier C, et al. G Protein signaling modulator-3 inhibits the inflammasome activity of NLRP3. J Biol Chem. 2014;289:33245-57 pubmed 出版商
  115. Guo C, Chen M, Fa Z, Lu A, Fang W, Sun B, et al. Acapsular Cryptococcus neoformans activates the NLRP3 inflammasome. Microbes Infect. 2014;16:845-54 pubmed 出版商
  116. Derangère V, Chevriaux A, Courtaut F, Bruchard M, Berger H, Chalmin F, et al. Liver X receptor ? activation induces pyroptosis of human and murine colon cancer cells. Cell Death Differ. 2014;21:1914-24 pubmed 出版商
  117. Huck O, Elkaim R, Davideau J, Tenenbaum H. Porphyromonas gingivalis-impaired innate immune response via NLRP3 proteolysis in endothelial cells. Innate Immun. 2015;21:65-72 pubmed 出版商
  118. Tseng W, Thein T, Kinnunen K, Lashkari K, Gregory M, D Amore P, et al. NLRP3 inflammasome activation in retinal pigment epithelial cells by lysosomal destabilization: implications for age-related macular degeneration. Invest Ophthalmol Vis Sci. 2013;54:110-20 pubmed 出版商
  119. Pigors M, Kiritsi D, Krümpelmann S, Wagner N, He Y, Podda M, et al. Lack of plakoglobin leads to lethal congenital epidermolysis bullosa: a novel clinico-genetic entity. Hum Mol Genet. 2011;20:1811-9 pubmed 出版商
  120. de Koning H, Rodijk Olthuis D, van Vlijmen Willems I, Joosten L, Netea M, Schalkwijk J, et al. A comprehensive analysis of pattern recognition receptors in normal and inflamed human epidermis: upregulation of dectin-1 in psoriasis. J Invest Dermatol. 2010;130:2611-20 pubmed 出版商
  121. Mayor A, Martinon F, De Smedt T, Petrilli V, Tschopp J. A crucial function of SGT1 and HSP90 in inflammasome activity links mammalian and plant innate immune responses. Nat Immunol. 2007;8:497-503 pubmed